Industry Research Reports

Home > Reports > Service & Software > Phenotypic Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Phenotypic Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-07-14

Pages: 105 Pages

Report ld: 6916134

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report provides a comprehensive view of the global market for Phenotypic Drug Discovery, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Phenotypic Drug Discovery market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Phenotypic Drug Discovery.

MARKET SEGMENTATION

By Company

Eurofins Discovery
Sygnature Discovery
PsychoGenics
siTOOLs Biotech
PhoreMost
Charles River
MaxWell
Arctoris

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Platform
Service

Segment by Application

Cancer
Viral Infection
Genetic Disease
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Phenotypic Drug Discovery companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Phenotypic Drug Discovery revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Phenotypic Drug Discovery revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Phenotypic Drug Discovery Product Introduction

1.2 Global Phenotypic Drug Discovery Market Size Forecast (2021–2032)

1.3 Phenotypic Drug Discovery Market Trends & Drivers

1.3.1 Phenotypic Drug Discovery Industry Trends

1.3.2 Phenotypic Drug Discovery Market Drivers & Opportunities

1.3.3 Phenotypic Drug Discovery Market Challenges

1.3.4 Phenotypic Drug Discovery Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Phenotypic Drug Discovery Players Revenue Ranking (2025)

2.2 Global Phenotypic Drug Discovery Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Phenotypic Drug Discovery Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Phenotypic Drug Discovery

2.6 Phenotypic Drug Discovery Market Competitive Analysis

2.6.1 Phenotypic Drug Discovery Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Phenotypic Drug Discovery Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Phenotypic Drug Discovery revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Phenotypic Drug Discovery Market Classification

3.1 Introduction by Type

3.1.1 Platform

3.1.2 Service

3.1.3 Global Phenotypic Drug Discovery Sales Value by Type

3.1.3.1 Global Phenotypic Drug Discovery Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Phenotypic Drug Discovery Sales Value, by Type (2021–2032)

3.1.3.3 Global Phenotypic Drug Discovery Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Cancer

4.1.2 Viral Infection

4.1.3 Genetic Disease

4.1.4 Others

4.2 Global Phenotypic Drug Discovery Sales Value by Application

4.2.1 Global Phenotypic Drug Discovery Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Phenotypic Drug Discovery Sales Value by Application (2021–2032)

4.2.3 Global Phenotypic Drug Discovery Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Phenotypic Drug Discovery Sales Value by Region

5.1.1 Global Phenotypic Drug Discovery Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Phenotypic Drug Discovery Sales Value by Region (2021–2026)

5.1.3 Global Phenotypic Drug Discovery Sales Value by Region (2027–2032)

5.1.4 Global Phenotypic Drug Discovery Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Phenotypic Drug Discovery Sales Value, 2021–2032

5.2.2 North America Phenotypic Drug Discovery Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Phenotypic Drug Discovery Sales Value, 2021–2032

5.3.2 Europe Phenotypic Drug Discovery Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Phenotypic Drug Discovery Sales Value, 2021–2032

5.4.2 Asia Pacific Phenotypic Drug Discovery Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Phenotypic Drug Discovery Sales Value, 2021–2032

5.5.2 South America Phenotypic Drug Discovery Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Phenotypic Drug Discovery Sales Value, 2021–2032

5.6.2 Middle East & Africa Phenotypic Drug Discovery Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Phenotypic Drug Discovery Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Phenotypic Drug Discovery Sales Value, 2021–2032

6.3 United States

6.3.1 United States Phenotypic Drug Discovery Sales Value, 2021–2032

6.3.2 United States Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Phenotypic Drug Discovery Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Phenotypic Drug Discovery Sales Value, 2021–2032

6.4.2 Europe Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Phenotypic Drug Discovery Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Phenotypic Drug Discovery Sales Value, 2021–2032

6.5.2 China Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

6.5.3 China Phenotypic Drug Discovery Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Phenotypic Drug Discovery Sales Value, 2021–2032

6.6.2 Japan Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Phenotypic Drug Discovery Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Phenotypic Drug Discovery Sales Value, 2021–2032

6.7.2 South Korea Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Phenotypic Drug Discovery Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Phenotypic Drug Discovery Sales Value, 2021–2032

6.8.2 Southeast Asia Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Phenotypic Drug Discovery Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Phenotypic Drug Discovery Sales Value, 2021–2032

6.9.2 India Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

6.9.3 India Phenotypic Drug Discovery Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Eurofins Discovery

7.1.1 Eurofins Discovery Profile

7.1.2 Eurofins Discovery Main Business

7.1.3 Eurofins Discovery Phenotypic Drug Discovery Products, Services, and Solutions

7.1.4 Eurofins Discovery Phenotypic Drug Discovery Revenue (US$ Million), 2021–2026

7.1.5 Eurofins Discovery Recent Developments

7.2 Sygnature Discovery

7.2.1 Sygnature Discovery Profile

7.2.2 Sygnature Discovery Main Business

7.2.3 Sygnature Discovery Phenotypic Drug Discovery Products, Services, and Solutions

7.2.4 Sygnature Discovery Phenotypic Drug Discovery Revenue (US$ Million), 2021–2026

7.2.5 Sygnature Discovery Recent Developments

7.3 PsychoGenics

7.3.1 PsychoGenics Profile

7.3.2 PsychoGenics Main Business

7.3.3 PsychoGenics Phenotypic Drug Discovery Products, Services, and Solutions

7.3.4 PsychoGenics Phenotypic Drug Discovery Revenue (US$ Million), 2021–2026

7.3.5 PsychoGenics Recent Developments

7.4 siTOOLs Biotech

7.4.1 siTOOLs Biotech Profile

7.4.2 siTOOLs Biotech Main Business

7.4.3 siTOOLs Biotech Phenotypic Drug Discovery Products, Services, and Solutions

7.4.4 siTOOLs Biotech Phenotypic Drug Discovery Revenue (US$ Million), 2021–2026

7.4.5 siTOOLs Biotech Recent Developments

7.5 PhoreMost

7.5.1 PhoreMost Profile

7.5.2 PhoreMost Main Business

7.5.3 PhoreMost Phenotypic Drug Discovery Products, Services, and Solutions

7.5.4 PhoreMost Phenotypic Drug Discovery Revenue (US$ Million), 2021–2026

7.5.5 PhoreMost Recent Developments

7.6 Charles River

7.6.1 Charles River Profile

7.6.2 Charles River Main Business

7.6.3 Charles River Phenotypic Drug Discovery Products, Services, and Solutions

7.6.4 Charles River Phenotypic Drug Discovery Revenue (US$ Million), 2021–2026

7.6.5 Charles River Recent Developments

7.7 MaxWell

7.7.1 MaxWell Profile

7.7.2 MaxWell Main Business

7.7.3 MaxWell Phenotypic Drug Discovery Products, Services, and Solutions

7.7.4 MaxWell Phenotypic Drug Discovery Revenue (US$ Million), 2021–2026

7.7.5 MaxWell Recent Developments

7.8 Arctoris

7.8.1 Arctoris Profile

7.8.2 Arctoris Main Business

7.8.3 Arctoris Phenotypic Drug Discovery Products, Services, and Solutions

7.8.4 Arctoris Phenotypic Drug Discovery Revenue (US$ Million), 2021–2026

7.8.5 Arctoris Recent Developments

8 Industry Chain Analysis

8.1 Phenotypic Drug Discovery Value Chain

8.2 Phenotypic Drug Discovery Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Phenotypic Drug Discovery Sales Model

8.5.2 Sales Channels

8.5.3 Phenotypic Drug Discovery Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Phenotypic Drug Discovery Market Trends

Table 2. Phenotypic Drug Discovery Market Drivers & Opportunities

Table 3. Phenotypic Drug Discovery Market Challenges

Table 4. Phenotypic Drug Discovery Market Restraints

Table 5. Global Phenotypic Drug Discovery Revenue by Company (US$ Million), 2021–2026

Table 6. Global Phenotypic Drug Discovery Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Phenotypic Drug Discovery Product Type

Table 9. Key Companies General Availability (GA) Timeline for Phenotypic Drug Discovery

Table 10. Global Phenotypic Drug Discovery Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Phenotypic Drug Discovery revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Phenotypic Drug Discovery Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Phenotypic Drug Discovery Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Phenotypic Drug Discovery Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Phenotypic Drug Discovery Sales Market Share in Value by Type (2021–2026)

Table 17. Global Phenotypic Drug Discovery Sales Market Share in Value by Type (2027–2032)

Table 18. Global Phenotypic Drug Discovery Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Phenotypic Drug Discovery Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Phenotypic Drug Discovery Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Phenotypic Drug Discovery Sales Market Share in Value by Application (2021–2026)

Table 22. Global Phenotypic Drug Discovery Sales Market Share in Value by Application (2027–2032)

Table 23. Global Phenotypic Drug Discovery Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Phenotypic Drug Discovery Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Phenotypic Drug Discovery Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Phenotypic Drug Discovery Sales Value by Region (%), 2021–2026

Table 27. Global Phenotypic Drug Discovery Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Phenotypic Drug Discovery Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Phenotypic Drug Discovery Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Phenotypic Drug Discovery Sales Value, (US$ Million), 2027–2032

Table 31. Eurofins Discovery Basic Information List

Table 32. Eurofins Discovery Description and Business Overview

Table 33. Eurofins Discovery Phenotypic Drug Discovery Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Phenotypic Drug Discovery Business of Eurofins Discovery (2021–2026)

Table 35. Eurofins Discovery Recent Developments

Table 36. Sygnature Discovery Basic Information List

Table 37. Sygnature Discovery Description and Business Overview

Table 38. Sygnature Discovery Phenotypic Drug Discovery Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Phenotypic Drug Discovery Business of Sygnature Discovery (2021–2026)

Table 40. Sygnature Discovery Recent Developments

Table 41. PsychoGenics Basic Information List

Table 42. PsychoGenics Description and Business Overview

Table 43. PsychoGenics Phenotypic Drug Discovery Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Phenotypic Drug Discovery Business of PsychoGenics (2021–2026)

Table 45. PsychoGenics Recent Developments

Table 46. siTOOLs Biotech Basic Information List

Table 47. siTOOLs Biotech Description and Business Overview

Table 48. siTOOLs Biotech Phenotypic Drug Discovery Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Phenotypic Drug Discovery Business of siTOOLs Biotech (2021–2026)

Table 50. siTOOLs Biotech Recent Developments

Table 51. PhoreMost Basic Information List

Table 52. PhoreMost Description and Business Overview

Table 53. PhoreMost Phenotypic Drug Discovery Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Phenotypic Drug Discovery Business of PhoreMost (2021–2026)

Table 55. PhoreMost Recent Developments

Table 56. Charles River Basic Information List

Table 57. Charles River Description and Business Overview

Table 58. Charles River Phenotypic Drug Discovery Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Phenotypic Drug Discovery Business of Charles River (2021–2026)

Table 60. Charles River Recent Developments

Table 61. MaxWell Basic Information List

Table 62. MaxWell Description and Business Overview

Table 63. MaxWell Phenotypic Drug Discovery Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Phenotypic Drug Discovery Business of MaxWell (2021–2026)

Table 65. MaxWell Recent Developments

Table 66. Arctoris Basic Information List

Table 67. Arctoris Description and Business Overview

Table 68. Arctoris Phenotypic Drug Discovery Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Phenotypic Drug Discovery Business of Arctoris (2021–2026)

Table 70. Arctoris Recent Developments

Table 71. Revenue (US$ Million) in Phenotypic Drug Discovery Business of Company 40 (2021–2026)

Table 72. Company 40 Recent Developments

Table 73. Key Raw Materials Lists

Table 74. Key Suppliers of Raw Materials Lists

Table 75. Phenotypic Drug Discovery Downstream Customers

Table 76. Phenotypic Drug Discovery Distributors List

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

List of Figures

Figure 1. Phenotypic Drug Discovery Product Picture

Figure 2. Global Phenotypic Drug Discovery Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Phenotypic Drug Discovery Sales Value (US$ Million), 2021–2032

Figure 4. Phenotypic Drug Discovery Report Years Considered

Figure 5. Global Phenotypic Drug Discovery Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Phenotypic Drug Discovery Revenue in 2025

Figure 7. Phenotypic Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Platform Picture

Figure 9. Service Picture

Figure 10. Global Phenotypic Drug Discovery Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Phenotypic Drug Discovery Sales Value Market Share by Type, 2025 & 2032

Figure 12. Product Picture of Cancer

Figure 13. Product Picture of Viral Infection

Figure 14. Product Picture of Genetic Disease

Figure 15. Product Picture of Others

Figure 16. Global Phenotypic Drug Discovery Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Phenotypic Drug Discovery Sales Value Market Share by Application, 2025 & 2032

Figure 18. North America Phenotypic Drug Discovery Sales Value (US$ Million), 2021–2032

Figure 19. North America Phenotypic Drug Discovery Sales Value by Country (%), 2025 vs 2032

Figure 20. Europe Phenotypic Drug Discovery Sales Value (US$ Million), 2021–2032

Figure 21. Europe Phenotypic Drug Discovery Sales Value by Country (%), 2025 vs 2032

Figure 22. Asia Pacific Phenotypic Drug Discovery Sales Value (US$ Million), 2021–2032

Figure 23. Asia Pacific Phenotypic Drug Discovery Sales Value by Subregion (%), 2025 vs 2032

Figure 24. South America Phenotypic Drug Discovery Sales Value (US$ Million), 2021–2032

Figure 25. South America Phenotypic Drug Discovery Sales Value by Country (%), 2025 vs 2032

Figure 26. Middle East & Africa Phenotypic Drug Discovery Sales Value (US$ Million), 2021–2032

Figure 27. Middle East & Africa Phenotypic Drug Discovery Sales Value by Country (%), 2025 vs 2032

Figure 28. Key Countries/Regions Phenotypic Drug Discovery Sales Value (%), 2021–2032

Figure 29. United States Phenotypic Drug Discovery Sales Value (US$ Million), 2021–2032

Figure 30. United States Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

Figure 31. United States Phenotypic Drug Discovery Sales Value by Application (%), 2025 vs 2032

Figure 32. Europe Phenotypic Drug Discovery Sales Value (US$ Million), 2021–2032

Figure 33. Europe Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

Figure 34. Europe Phenotypic Drug Discovery Sales Value by Application (%), 2025 vs 2032

Figure 35. China Phenotypic Drug Discovery Sales Value (US$ Million), 2021–2032

Figure 36. China Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

Figure 37. China Phenotypic Drug Discovery Sales Value by Application (%), 2025 vs 2032

Figure 38. Japan Phenotypic Drug Discovery Sales Value (US$ Million), 2021–2032

Figure 39. Japan Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

Figure 40. Japan Phenotypic Drug Discovery Sales Value by Application (%), 2025 vs 2032

Figure 41. South Korea Phenotypic Drug Discovery Sales Value (US$ Million), 2021–2032

Figure 42. South Korea Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

Figure 43. South Korea Phenotypic Drug Discovery Sales Value by Application (%), 2025 vs 2032

Figure 44. Southeast Asia Phenotypic Drug Discovery Sales Value (US$ Million), 2021–2032

Figure 45. Southeast Asia Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

Figure 46. Southeast Asia Phenotypic Drug Discovery Sales Value by Application (%), 2025 vs 2032

Figure 47. India Phenotypic Drug Discovery Sales Value (US$ Million), 2021–2032

Figure 48. India Phenotypic Drug Discovery Sales Value by Type (%), 2025 vs 2032

Figure 49. India Phenotypic Drug Discovery Sales Value by Application (%), 2025 vs 2032

Figure 50. Phenotypic Drug Discovery Value Chain

Figure 51. Phenotypic Drug Discovery Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Phenotypic Drug Discovery market? zhanKai

The top companies in the global Phenotypic Drug Discovery market are Eurofins Discovery、Sygnature Discovery、PsychoGenics.

Related Reports

Global Phenotypic Drug Discovery Market Research Report 2026
The global Phenotypic Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 110
USD 2900.00
(Single User License)
Global Phenotypic Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Phenotypic Drug Discovery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 125
USD 4900.00
(Single User License)
Phenotypic Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 90
USD 3950.00
(Single User License)
Global Phenotypic Drug Discovery Market Research Report 2025
The global market for Phenotypic Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 72
USD 2900.00
(Single User License)
Global Phenotypic Drug Discovery Market Insights, Forecast to 2030
Market Analysis and Insights: Global Phenotypic Drug Discovery Market
Published Date: 2024-04-11
Pages: 99
USD 4900.00
(Single User License)
Global Phenotypic Drug Discovery Market Research Report 2024
The global Phenotypic Drug Discovery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 70
USD 2900.00
(Single User License)
Phenotypic Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-06
Pages: 97
USD 3950.00
(Single User License)

Global Phenotypic Drug Discovery Market Research Report 2026
The global Phenotypic Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 110
USD 2900.00 (Single User License)
Global Phenotypic Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Phenotypic Drug Discovery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 125
USD 4900.00 (Single User License)
Phenotypic Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 90
USD 3950.00 (Single User License)
Global Phenotypic Drug Discovery Market Research Report 2025
The global market for Phenotypic Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 72
USD 2900.00 (Single User License)
Global Phenotypic Drug Discovery Market Insights, Forecast to 2030
Market Analysis and Insights: Global Phenotypic Drug Discovery Market
Published: 2024-04-11
Pages: 99
USD 4900.00 (Single User License)
Global Phenotypic Drug Discovery Market Research Report 2024
The global Phenotypic Drug Discovery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 70
USD 2900.00 (Single User License)
Phenotypic Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-06
Pages: 97
USD 3950.00 (Single User License)